4//SEC Filing
Fenton Mary Kay 4
Accession 0000899243-22-030928
CIK 0001827506other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 4:29 PM ET
Size
5.0 KB
Accession
0000899243-22-030928
Insider Transaction Report
Form 4
Fenton Mary Kay
Chief Financial Officer
Transactions
- Award
Common Stock
2022-09-10+80,000→ 81,000 total
Footnotes (1)
- [F1]The shares reported in this transaction represent restricted stock units ("RSUs") issued under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest as to 50% of the underlying shares on July 1, 2023 and the remaining 50% on July 1, 2024, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Talaris Therapeutics, Inc.
CIK 0001827506
Entity typeother
Related Parties
1- filerCIK 0001378589
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 4:29 PM ET
- Size
- 5.0 KB